Table 1.
Variable number | Factor | Values |
---|---|---|
x1 | Gender | Male = 1, female = 0 |
x2 | Age | 32–83 years |
x3 | Pathological type of primary lesion | 1 = adenocarcinoma, 2 = squamous cell carcinoma, 3 = other |
x4 | Number of metastases | 1–3 |
x5 | Sum of tumor diameters before treatment | 0.7–7.1 cm |
x6 | Sum of peritumoral edema diameters before treatment | 1.1–11.5 cm |
x7 | Maximum value of sum of metastasis diameters | 1.2–11.7 cm |
x8 | Time of appearance of maximum value of sum of metastasis diameters | 0–30 months |
X9 | Presence of radiological tumor progression during brain metastasis treatment | 0 = not present, 1 = present |
x10 | Maximum value of sum of peritumoral edema diameters | 0–15.4 cm |
x11 | Time of appearance of maximum value of sum of peritumoral edema diameters | 0–30 months |
x12 | Number of appearances of Cho/Cr > 2 | 1–3 |
x13 | Number of island (yu‐yuan) signs | 1–3 |
x14 | Number of appearances of high‐signal ring in T2 FLAIRs | 1–3 |
y | Survival period | 6–30 + months |
Zero months in x8 and x11 represent data prior to treatment. FLAIR, fluid‐attenuated inversion recovery.